---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-031818"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2025-06-17T23:59:59+00:00"
generated_at: "2026-05-19T04:34:15.988037+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Avalo stockholders elect eight directors, approve say-on-pay and auditor ratification at 2025 annual meeting

## Summary
- All eight director nominees elected; top vote-getter Michael Heffernan with 8,022,534 shares for.
- Say-on-pay advisory resolution approved with 8,003,142 votes in favor (99.7% of votes cast).
- Ratification of Ernst & Young as independent auditor for FY 2025 passed with 9,782,455 votes for.
- Approximately 90% of outstanding shares (9.79M of 10.83M) were represented at the meeting.

## SEC filing metadata
- accession: 0001628280-25-031818
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2025-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828025031818/0001628280-25-031818-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828025031818/avtx-20250617.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-031818
- JSON: https://secwatch.observer/filing/0001628280-25-031818.json
- Plain text: https://secwatch.observer/filing/0001628280-25-031818.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.